Biopsy Devices Market to Reach USD 2.83 Billion by 2031 Driven by Minimally Invasive Diagnostics and Image-Guided Procedures, Says Mordor Intelligence

HYDERABAD, India, Oct. 13, 2026 /PRNewswire/ -- According to the latest report by Mordor Intelligence, the biopsy devices market is estimated at USD 2.33 billion in 2026 and is projected to reach USD 2.83 billion by 2031, registering a CAGR of 3.97% during the forecast period. Market expansion is supported by increasing demand for early cancer diagnosis, the growing adoption of image-guided biopsy procedures, advancements in minimally invasive sampling technologies, and expanding diagnostic capabilities across healthcare facilities. 

The growth of the biopsy devices market is closely linked to the increasing need for accurate tissue sampling to diagnose cancer and other abnormalities. Hospitals, diagnostic and imaging centers, and ambulatory surgical centers are incorporating biopsy procedures into diagnostic pathways for breast, lung, prostate, colorectal, and other conditions. Improvements in needle-based instruments and vacuum-assisted biopsy systems are helping clinicians obtain tissue samples for histopathological assessment and treatment planning. 

Technological advancements are playing a significant role in shaping the market landscape. Manufacturers are focusing on improved needle designs, image-guided sampling systems, and instruments compatible with advanced imaging platforms. Developments in robotic navigation, artificial intelligence-assisted imaging, and disposable biopsy products are also creating opportunities to improve targeting, procedural workflows, and infection control. As cancer screening and diagnostic services expand, demand for biopsy devices is expected to remain an important component of tissue-based diagnosis. 

Biopsy Devices Market Share by Region 

North America represents the largest share of the biopsy devices market, supported by established healthcare infrastructure, advanced diagnostic imaging capabilities, and widespread access to cancer screening and diagnostic services. The region benefits from the adoption of minimally invasive biopsy techniques, established medical device distribution networks, and continued investment in oncology diagnostics. Growing use of image-guided procedures and advanced sampling technologies is supporting demand across hospitals and specialized diagnostic centers. 

Asia-Pacific is emerging as a key growth region in the biopsy devices market. Expanding healthcare infrastructure, increasing awareness of early cancer diagnosis, and rising demand for diagnostic services are creating opportunities for device manufacturers. Countries including China, Japan, India, South Korea, and Australia are investing in healthcare modernization and oncology capabilities, supporting the adoption of biopsy technologies across clinical settings. 

Biopsy Devices Market Trends & Forecast 

Growing Adoption of Image-Guided Biopsy Procedures 

Image-guided biopsy techniques are becoming increasingly important because they help clinicians target suspicious tissue using imaging modalities such as ultrasound, computed tomography, and other diagnostic systems. These procedures can support sampling of lesions that may be difficult to access using conventional approaches. 

Manufacturers are developing biopsy instruments compatible with advanced imaging platforms to improve targeting and procedural efficiency. Continued improvements in imaging quality, navigation technologies, and instrument design are expected to support wider adoption of image-guided biopsy procedures. 

Increasing Integration of Artificial Intelligence and Navigation Technologies 

Artificial intelligence and advanced navigation technologies are creating opportunities to improve biopsy planning and targeting. AI-assisted imaging tools can help clinicians interpret medical images and identify areas requiring further investigation, while navigation systems can support access to selected lesions. 

The integration of these technologies with biopsy instruments and imaging platforms may help streamline procedures and support more consistent targeting. Continued development will depend on clinical validation, workflow compatibility, and the ability of healthcare facilities to adopt advanced diagnostic systems. 

Expanding Diagnostic Infrastructure and Outpatient Procedures 

The expansion of diagnostic imaging centers and ambulatory surgical facilities is creating additional opportunities for biopsy device manufacturers. Healthcare providers are seeking instruments that support efficient procedures, straightforward setup, and reliable sampling across different care settings. 

The growing availability of outpatient diagnostic services is also encouraging manufacturers to develop convenient instruments and standardized procedure kits. However, equipment costs, training requirements, and differences in healthcare access remain important considerations for broader adoption. 

"As the biopsy devices market evolves through advancements in minimally invasive sampling and image-guided diagnostics, decision-makers benefit from research grounded in transparent sourcing, consistent validation, and balanced market assessment. Mordor Intelligence provides a structured view of market developments, competitive activity, and demand factors," says Soumya Goud, Senior Research Manager, Mordor Intelligence. 

Biopsy Devices Market Segmentation Overview 

By Product 

• Needle-Based Biopsy Instruments 
• Core Biopsy Devices 
• Aspiration Biopsy Needles 
• Vacuum-Assisted Biopsy Devices 
• Procedure Trays 
• Localization Wires 
• Other Products 

By Application 

• Breast Biopsy 
• Lung Biopsy 
• Colorectal Biopsy 
• Prostate Biopsy 
• Other Applications 

By End User 

• Hospitals 
• Diagnostic and Imaging Centers 
• Ambulatory Surgical Centers 
• Others 

By Geography 

• North America 
  • United States 
  • Canada 
  • Mexico 
• Europe 
  • Germany 
  • United Kingdom 
  • France 
  • Italy 
  • Spain 
  • Rest of Europe 
• Asia-Pacific 
  • China 
  • Japan 
  • India 
  • South Korea 
  • Australia 
  • Rest of Asia-Pacific 
• Middle East and Africa 
  • GCC 
  • South Africa 
  • Rest of Middle East and Africa 
• South America 
  • Brazil 
  • Argentina 
  • Rest of South America 

For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/global-biopsy-devices-market-industry?utm_source=prnewswire 

Biopsy Devices Market Competitive Outlook 

The biopsy devices market features established medical device manufacturers and specialized providers focusing on needle-based instruments, vacuum-assisted biopsy systems, localization products, and image-guided sampling technologies. Market participants are investing in product innovation, improved instrument design, procedural efficiency, and compatibility with advanced diagnostic imaging to strengthen their market positions. 

The competitive landscape is also influenced by the growing demand for minimally invasive procedures, infection-control requirements, and the adoption of advanced diagnostic technologies. Companies are focusing on expanding product portfolios, strengthening distribution networks, and developing instruments for specialized clinical applications. Clinical performance, product reliability, regulatory compliance, and healthcare provider relationships remain important competitive factors. 

Major Companies in the Biopsy Devices Market include: 

• Argon Medical Devices 
• Cook Medical 
• Hologic, Inc. 
• Becton, Dickinson and Company 
• Boston Scientific Corporation 

Check out related reports published by Mordor Intelligence: 

• Oral Cancer Rapid Test Kit Market: The Oral Cancer Rapid Test Kit Market is expected to grow from USD 2.01 billion in 2026 to USD 2.58 billion by 2031, registering a CAGR of 5.12%, supported by rising oral cancer incidence, increasing demand for non-invasive early detection, and expanding saliva-based screening through dental clinics and diagnostic centers.  
• Bladder Cancer Detection Kits Market: The Bladder Cancer Detection Kits Market is projected to expand from USD 1.08 billion in 2026 to USD 1.67 billion by 2031, at a 9.25% CAGR, driven by growing demand for non-invasive urine-based testing, rising bladder cancer surveillance needs, and increasing adoption of molecular biomarkers for diagnosis and recurrence monitoring.  
• Solid Tumor Testing Market: The Solid Tumor Testing Market is estimated to grow from USD 33.57 billion in 2026 to USD 48.42 billion by 2031, registering a CAGR of 7.60%, supported by increasing adoption of precision oncology, advances in next-generation sequencing, expanding liquid biopsy applications, and growing demand for molecular profiling to guide targeted cancer treatments. 

About Mordor Intelligence 

Mordor Intelligence is a global market intelligence firm, founded in 2014, helping businesses make informed decisions through data-driven insights, industry expertise, and advanced analytics. With 550+ domain experts and on-ground specialists across 150+ countries, the company delivers comprehensive intelligence across aerospace & defense, agriculture, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, and logistics. 

Its offerings include syndicated industry reports, custom research and advisory, and subscription platforms such as Data Center Intelligence. Mordor Intelligence is ISO 9001:2015 and ISO/IEC 27001:2022 certified, a member of ESOMAR and the Market Research Society of India, and a four-time Great Place to Work® honoree. Learn more at mordorintelligence.com.

For any inquiries or to access the full report, please contact:      
[email protected]   
https://www.mordorintelligence.com    

SOURCE Mordor Intelligence Private Limited